<bill session="116" type="h" number="6839" updated="2023-01-11T13:42:56Z">
  <state datetime="2020-05-12">REFERRED</state>
  <status>
    <introduced datetime="2020-05-12"/>
  </status>
  <introduced datetime="2020-05-12"/>
  <titles>
    <title type="display">To direct the Comptroller General of the United States to submit a report describing the response of certain entities to the COVID-19 pandemic with respect to the development, regulatory evaluation, and deployment of diagnostic tests.</title>
    <title type="official" as="introduced">To direct the Comptroller General of the United States to submit a report describing the response of certain entities to the COVID-19 pandemic with respect to the development, regulatory evaluation, and deployment of diagnostic tests.</title>
  </titles>
  <sponsor bioguide_id="S001209"/>
  <cosponsors>
    <cosponsor bioguide_id="G000588" joined="2020-05-12"/>
  </cosponsors>
  <actions>
    <action datetime="2020-05-12">
      <text>Introduced in House</text>
    </action>
    <action datetime="2020-05-12" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="116" type="h" number="6800" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Blood and blood diseases"/>
    <term name="Cardiovascular and respiratory health"/>
    <term name="Congressional oversight"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Emergency medical services and trauma care"/>
    <term name="Government studies and investigations"/>
    <term name="Health facilities and institutions"/>
    <term name="Infectious and parasitic diseases"/>
    <term name="Medical tests and diagnostic methods"/>
    <term name="State and local government operations"/>
  </subjects>
  <amendments/>
  <summary date="2020-06-11T16:33:11Z" status="Introduced in House">This bill requires the Government Accountability Office (GAO) to report on diagnostic tests to diagnose COVID-19 (i.e., coronavirus disease 2019) or detect the virus that causes the disease. Specifically, the report must describe the response of, among others, laboratories, diagnostic test manufacturers, and government entities with respect to the development, regulatory evaluation, and deployment of diagnostic tests. The GAO must also assess standards, guidance, clinical processes, and intergovernmental coordination related to COVID-19 testing.</summary>
</bill>
